NCT03150953 is a NA clinical trial of MRI-safe bore covering in Anesthesia; Hypothermia, sponsored by Andrew Matisoff.

Who is sponsoring NCT03150953?

NCT03150953 is sponsored by Andrew Matisoff.

What drugs are being tested in NCT03150953?

Interventions in NCT03150953: MRI-safe bore covering.

What condition does NCT03150953 study?

NCT03150953 studies Anesthesia; Hypothermia, Congenital Heart Disease.

Is NCT03150953 still recruiting?

NCT03150953 is currently completed. Last updated 28 March 2019.

Last reviewed 2019-03-28 · How we verify

NCT03150953

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of a Novel Patient Warming System During MRI

Completed NA Last updated 28 March 2019

What this trial tests

NA trial testing MRI-safe bore covering in Anesthesia; Hypothermia in 60 participants. Completed in 30 November 2018.

Timeline

26 May 2016

Primary endpoint
1 May 2018

30 November 2018

Quick facts

Lead sponsor	Andrew Matisoff
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	60
Start date	26 May 2016
Primary completion	1 May 2018
Estimated completion	30 November 2018
Sites	1 location across United States

Drugs / interventions tested

MRI-safe bore covering

Conditions studied

Anesthesia; Hypothermia — all drugs for Anesthesia; Hypothermia →
Congenital Heart Disease — all drugs for Congenital Heart Disease →

Sponsor

Andrew Matisoff

Who can join

Under 7, any sex, with Anesthesia; Hypothermia or Congenital Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients under deep sedation and general anesthesia lose heat to their surrounding environment. Hypothermia after anesthesia is associated with worse patient outcomes, including increased number of infections and cardiovascular complications. Cardiac MRI scans performed for patients who require general anesthesia can cause a loss of body heat. Several mechanisms exist for reducing hypothermia under anesthesia including forced air warmers, fluid warmers, radiant warmers, and chemical warmers. Unfortunately, there are no MRI-compatible systems which allow patient warming and prevention of hypothermia in anesthetized patient in the MRI-scanner. This study is testing a non-invasive device that warms patients under clinically indicated general anesthesia in the MRI scanner. This device will keep in the heat made by the MRI scanner.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03150953 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Andrew Matisoff
Last refreshed: 28 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03150953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing